BRONQUIECTASIAS SEPAR PDF

Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: 76, Published: Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: , Published: Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: 54, Published:

Author: Grotaxe Shakall
Country: Portugal
Language: English (Spanish)
Genre: Science
Published (Last): 14 January 2006
Pages: 462
PDF File Size: 11.64 Mb
ePub File Size: 12.92 Mb
ISBN: 988-2-50963-740-1
Downloads: 86597
Price: Free* [*Free Regsitration Required]
Uploader: Dom

Monografías de Archivos de Bronconeumología

Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Almost 10 years later, considerable scientific advances have been made in both the treatment and the evaluation and diagnosis of this disease, and the original guidelines have been updated to include the latest therapies available for bronchiectasis.

En la tabla 6 aparecen las principales indicaciones para el trasplante Chest physiotherapy techniques in bronchiectasis.

Read this article in English.

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Semin Respir Crit Care Med. Lung transplantation for cystic fibrosis and bronchiectasis. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. A randomised, double-blind, placebo-controlled trial.

Normativa sobre el tratamiento de las bronquiectasias en el adulto | Archivos de Bronconeumología

Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex. Controlled trial of ceftazidime vs. Mortality in non-cystic fibrosis bronchiectasis: British Thoracic Society Research Committee.

Arch Phys Med Rehabil. Asimismo ha sido investigador principal de proyectos financiados por Bayer y Gilead. Bronchiectasis in a diverse US population.

TOP Related Posts  EL CERCO DE LENINGRADO PDF

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Quality of Life bronchiectasis questionnaire. Staphylococcus aureus resistente a la meticilina; vo: En la tabla 9 se puede observar la cadencia de visitas y pruebas recomendadas a realizar. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. Calidad de la evidencia baja.

British Thoracic Society guideline for non-CF bronchiectasis. La dosis de colistimetato de sodio depende de la eficacia del nebulizador utilizado. Firma de consentimiento informado. Quality of Life bronchiectasis questionnaire.

Calidad de la sepag baja 6,7. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Cochrane Database Syst Rev. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Combined inhaled bronquiecctasias and long acting beta2-agonists for children and adults with bronchiectasis. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction.

Microbiologic follow-up study in adult bronchiectasis. You can change the settings or obtain more information by clicking sepaf. Primer cultivo positivo por P.

Algoritmo para el manejo de las agudizaciones.

Chang AB, Bilton D. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Respir Med,pp. Las complicaciones suelen ser escasas y relacionadas con el acceso venoso. Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.

TOP Related Posts  DIN EN 1176-3 PDF

Si la respuesta es insuficiente: Posibilidad de tratamiento oral efectivo. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction.

Effect of long-term, low-dose erytrhomicin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis.

Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.

Almost 10 years later, considerable scientific advances have been made in both the treatment and the evaluation and diagnosis of sepr disease, and the original guidelines have been updated to include the latest therapies available for bronchiectasis. Ann Am Thorac Soc. Continuing navigation will be considered as acceptance of this use.

Kellett F, Robert NM. Finalmente, la calidad de la evidencia y la fuerza de las recomendaciones se han establecido siguiendo las directrices de la propuesta GRADE anexos 1 y 2.